After clinical trials, Ocuvit capsules were recognized as the best in Croatia. But this does not mean that they are a panacea for all eye diseases. In severe and advanced cases, they can only alleviate the patient's condition and improve the quality of life. For mild or moderate impairments, Ocuvit acts on the cells and tissues of the organs of the visual apparatus to gradually improve vision. For best results, take the capsules as directed.
Unlike many modern drugs with an aggressive effect, Ocuvit is quite mild. Thanks to its active ingredients, it can reduce or eliminate pain, relieve muscle spasms, relieve inflammation, prevent the spread of infection, and temporarily improve vision. However, in order to achieve a permanent effect and to activate the mechanisms of natural regeneration of damaged tissues, the components of the composition must reach a certain concentration. Therefore, the course of treatment is at least 30 days, in some cases it is recommended to extend it to 2-3 months depending on the severity of the disorders. It is best to take Ocuvit 1 capsule in the morning and evening before or during a meal. If the course is extended, you can take a one-week break after every month of use.
Capsules are also suitable for the prevention of eye diseases and can also be used to relieve eye fatigue and normalize intraocular pressure during intense work and long-term stress. In addition, their use during the recovery period after surgery is appropriate. For prevention, Ocuvit is taken 1 capsule a day for 10-15 days. This is guaranteed vision support and protection.
Visual impairment can occur for various reasons and has a specific course. Despite all the differences, eye problems have a number of common symptoms that indicate the use of Ocuvit capsules:
The product has no identified side effects. The concentration of active substances does not cause allergic reactions, there is no irritation from the gastrointestinal tract, nervous and other systems. The drug is contraindicated for cancer and serious heart problems.